Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gibson

Showing results (541-550 of 577) with videos related to

Pageof 58
Sort By:
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
Plos Pathogens|March 31, 2021
Staphylococcus aureus cell wall structure and dynamics during host-pathogen interactionJoshua A F Sutton, Oliver T Carnell, Lucia Lafage, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosisYingze Zhang, Mao Jiang, Mehdi Nouraie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary FibrosisDaniel J Kass, Mehdi Nouraie, Marilyn K Glassberg, et al.
Burns : Journal of the International Society for Burn Injuries|June 8, 2021
A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burnsAngela L F Gibson, James H Holmes, Jeffrey W Shupp, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Plos Pathogens|September 16, 2021
Commensal bacteria augment Staphylococcus aureus infection by inactivation of phagocyte-derived reactive oxygen speciesJosie F Gibson, Grace R Pidwill, Oliver T Carnell, et al.
Annals of the American Thoracic Society|July 21, 2015
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis ProtocolDavid R Moller, Laura L Koth, Lisa A Maier, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognosesRehan A Kahloon, Jianmin Xue, Arpit Bhargava, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
Inhibition and role of let-7d in idiopathic pulmonary fibrosisKusum V Pandit, David Corcoran, Hanadie Yousef, et al.
Pageof 58

Showing results (541-550 of 577) with videos related to

Sort By:
Pageof 58
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
Plos Pathogens|March 31, 2021
Staphylococcus aureus cell wall structure and dynamics during host-pathogen interactionJoshua A F Sutton, Oliver T Carnell, Lucia Lafage, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosisYingze Zhang, Mao Jiang, Mehdi Nouraie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2019
Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary FibrosisDaniel J Kass, Mehdi Nouraie, Marilyn K Glassberg, et al.
Burns : Journal of the International Society for Burn Injuries|June 8, 2021
A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burnsAngela L F Gibson, James H Holmes, Jeffrey W Shupp, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Plos Pathogens|September 16, 2021
Commensal bacteria augment Staphylococcus aureus infection by inactivation of phagocyte-derived reactive oxygen speciesJosie F Gibson, Grace R Pidwill, Oliver T Carnell, et al.
Annals of the American Thoracic Society|July 21, 2015
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis ProtocolDavid R Moller, Laura L Koth, Lisa A Maier, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognosesRehan A Kahloon, Jianmin Xue, Arpit Bhargava, et al.
American Journal of Respiratory and Critical Care Medicine|April 17, 2010
Inhibition and role of let-7d in idiopathic pulmonary fibrosisKusum V Pandit, David Corcoran, Hanadie Yousef, et al.
Pageof 58